Life Sciences and Biotech : Business Brexit Readiness Event

Date: October 24, 2019

Location: Novotel, Cardiff. Wales.

UK

MediWales is working with the BIA, One Nucleus, BioNow and BioPartner UK will be holding and supporting consortia events across the UK aimed at helping biotech and  life science companies to prepare for Brexit.

We are aiming to provide multiple channels for life science businesses (particularly SMEs) to secure the most up-to-date information on Brexit and its possible impacts. The events will give companies the latest government guidance and advice on Brexit preparedness and allow discussion and feedback. We have approached UK Government, Office for Life Sciences representatives to attend and answer your questions directly, and there will be a range of help and guidance available as we approach 31 October.

Find out more and REGISTER your place here

For further information or to discuss in more detail please get in touch with Katherine Maxwell.

Webinar: Innovation in point-of-care diagnostics for sepsis and bloodstream infections

Date: November 26, 2019

International | UK

Join this GARDP webinar this November to hear from Longitude Prize teams developing diagnostics for sepsis.

Innovation in point-of-care diagnostics for sepsis and bloodstream infections

---

Speakers:

• Till Bachmann, University of Edinburgh, UK
• Amrita Sukrity, SpotSense, India
• David Anderson, Burnet Institute, Australia

Moderator: Caroline Purslow, Nesta Challenges

In this webinar our moderator Caroline Purslow (Nesta Challenges) will welcome three speakers.

Till Bachmann will give an overview of recent advances in AMR diagnostics development. He will discuss:

1. State of the art approaches for diagnosing infections and AMR
2. Pipeline of promising tests
3. Challenges of adoption

Amrita Sukrity will draw from her experience as a founder of SpotSense and talk about diagnosis of neonatal sepsis at the community level. Topics discussed will include:

1. Challenges across diagnosing newborn sepsis in NICU vs. in the community
2. Identifying different phases of sepsis by combining risk parameters and biomarker data
3. Creating outlines for biomarker-based differential diagnosis: work ahead

And finally, David Anderson’s presentation ‘CD64 as a host-response biomarker in sepsis and severe infections’ will cover:

1. Limitations of flow cytometry for CD64 as a diagnostic tool of sepsis and severe infections in emergency situations
2. Novel observations on CD64 biology that should facilitate more sensitive a point-of-care (POC) diagnostic tests for sepsis and severe infections
3. The ongoing development of a POC diagnostic test for neutrophil CD64

The presentation will be followed by a Q&A session.

---

Register here for this live webinar including interactive Q&A session on 26 November 2019, 9:30 am – 11:00 am CET (2:00 pm – 3:30 pm IST, 7:30 pm – 9:00 pm AEDT). Find your time zone here.

If you have questions or comments, please let us know. Do so by submitting them via the ‘Talk to an expert’ feature or contact us per email: revive@gardp.org.

REGISTER NOW!

SEHTA 2020 International MedTech Expo & Conference Devices, Diagnostics, Digital

Date: March 26, 2020

UK

Thursday 26th March 2020

Hilton London Tower Bridge, Tooley Street, London SE1 2BY

Over the last 15 years, South East Health Technologies Alliance (SEHTA) has developed an excellent reputation for support of its 1,300 members, especially SMEs, through its one to one mentoring, fund-finding, consultancy and events programme.

In 2020, for the first time, SEHTA is organising a major new international event in London designed to take the programme of support to another level.

We cordially invite you to join us on Thursday 26th March 2020 for SEHTAs first International MedTech Expo & Conference aimed at SMEs, Corporates, Academics & NHS Healthcare Providers.

The conference and expo aims to help delegates:

Understand: Make sense of the complexities of healthcare support and challenges of accessing the NHS

Find: Funding opportunities (public sector, private, NHS)

Navigate: Regulatory, legal and IP issues

Identify: Current clinical challenges in the NHS

Opportunity: to arrange a 1:1 with other delegates using our 1:1 portal (available from January 2020)